Emerging markets look to 2021 as Goldman adds to bullish calls7 min read 23 Nov 2020, 06:33 PM IST
The stakes for lower- and middle-income nations are immense as the Astra vaccine costs a fraction of the price set by Pfizer and will be manufactured in multiple countries, from India to Brazil
It may come down to another pharmaceutical breakthrough to set the tone for emerging markets headed toward 2021.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Select your Category